Paratek Pharma launches $125M convertible debt offering

|About: Paratek Pharmaceutical... (PRTK)|By:, SA News Editor

Paratek Pharmaceuticals (NASDAQ:PRTK) initiates a $125M direct offering of convertible senior subordinated notes due 2024. Price, yield and terms have yet to be announced.

Shares are down a fraction after hours.

Subscribe for full text news in your inbox